Blopress Plus 8/12.5 mg
Blopress Plus 8/12.5 mg is a medicine authorised by Swissmedic under authorisation number 55247. The authorisation holder is Cheplapharm Schweiz GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 11 February 2000 and the authorisation is valid without a time limit. ATC code C09DA06 places the medicine in the group Agents acting on the renin-angiotensin system.
| Authorisation number | 55247 |
|---|---|
| Name | Blopress Plus 8/12.5 mg |
| Full name | Blopress Plus 8/12.5 mg, Tabletten |
| Authorisation holder | Cheplapharm Schweiz GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C09DA06 |
| First authorisation | 11 February 2000 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Blopress Plus 8/12.5 mg, Tabletten | B | 23 June 2000 |
| 2 | Blopress Plus 16/12.5 mg, Tabletten | B | 11 February 2000 |
| 3 | Blopress Plus 32/12.5 mg, Tabletten | B | 04 August 2009 |
| 4 | Blopress Plus 32/25 mg, Tabletten | B | 04 August 2009 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 12 | 28 | Tablette(n) | C09DA06 | 02.07.2. | B |
| 16 | 98 | Tablette(n) | C09DA06 | 02.07.2. | B |
| 4 | 28 | Tablette(n) | C09DA06 | 02.07.2. | B |
| 8 | 98 | Tablette(n) | C09DA06 | 02.07.2. | B |
| 26 | 28 | Tablette(n) | C09DA06 | 02.07.2. | B |
| 28 | 98 | Tablette(n) | C09DA06 | 02.07.2. | B |
| 34 | 28 | Tablette(n) | C09DA06 | 02.07.2. | B |
| 36 | 98 | Tablette(n) | C09DA06 | 02.07.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Blopress Plus 8/12.5 mg authorised in Switzerland?
Yes. Blopress Plus 8/12.5 mg is authorised by Swissmedic under authorisation number 55247, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Blopress Plus 8/12.5 mg have?
Blopress Plus 8/12.5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Blopress Plus 8/12.5 mg?
The authorisation holder is Cheplapharm Schweiz GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.